RT Journal Article
SR Electronic
T1 COVID-19 testing and vaccine willingness: Cross-sectional survey in a culturally diverse community in Sydney, Australia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.25.21265503
DO 10.1101/2021.10.25.21265503
A1 Ayre, Julie
A1 Muscat, Danielle M
A1 Mac, Olivia
A1 Batcup, Carys
A1 Cvejic, Erin
A1 Pickles, Kristen
A1 Dolan, Hankiz
A1 Bonner, Carissa
A1 Mouwad, Dana
A1 Zachariah, Dipti
A1 Turalic, Una
A1 Santalucia, Yyvonne
A1 Chen, Tingting
A1 Vasic, Gordana
A1 McCaffery, Kirsten
YR 2021
UL http://medrxiv.org/content/early/2021/10/26/2021.10.25.21265503.abstract
AB Objective The current study examined patterns in COVID-19 testing and vaccination intentions across multiple language groups in Greater Western Sydney, Australia.Methods Participants completed a cross-sectional survey available from March 21 to July 9, 2021 in Sydney, Australia. Surveys were available in English or translated (11 languages). Participants could complete surveys independently or with support from bilingual staff. Logistic regression models using post-stratification weighted frequencies identified factors associated with testing and vaccination intentions.Results Most of the 708 participants (88%, n=622) were not born in Australia; 31% reported that they did not speak English well or at all (n=220); 70% had no tertiary qualifications (n=497); and 41% had inadequate health literacy (n=290). Most participants reported high testing intention (77.2%, n=546), with differences observed across language groups (p<0.001). The most frequently reported barrier to testing was concerns about infection at the clinic (26.1%). Half (53.0%) reported willingness to get a COVID-19 vaccine if recommended to them (n=375); 18% were unwilling (n=127), and the remainder unsure (29%, n=205). These proportions varied significantly by language group (p<0.001). Participants were more likely to be unwilling/hesitant if they were female (p=0.02) or did not use Australian commercial information sources (p=0.01). Concerns about side effects (30.4%, n=102) and safety (23.9%, n=80), were key reported barriers to vaccination.Conclusion Different language groups have unique and specific needs to support uptake of COVID-19 testing and vaccination. Health services must work collaboratively with culturally and linguistically diverse communities to provide tailored support to encourage COVID-19 testing and vaccination.Lay summary708 adults living in Sydney, Australia, who did not speak English as their main language at home took part in a survey about COVID-19 vaccination and testing.Participants could complete the survey online (English/translated) or with support from bilingual staff. The survey was available in 11 languages.Three quarters of participants (77%) reported they would get tested for COVID-19 if they had symptoms ‘no matter what.’ The most common barrier was concern about getting infected at the testing clinic.53% of participants reported that they would get a COVID-19 vaccine if it was recommended to them. 18% reported that they wouldn’t get the vaccine, and 29% were unsure. The main barriers were concerns about vaccine side effects and safety.Intentions to get tested for COVID-19 or to get vaccinated varied significantly across language groups. Participants who were female, or who did not use Australian commercial information sources were more likely to be unwilling or unsure about getting a COVID-19 vaccine.Different language groups have unique and specific needs to support uptake of COVID-19 testing and vaccination. Health services must work collaboratively with culturally and linguistically diverse communities to provide tailored support to encourage COVID-19 testing and vaccination.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was not supported by specific project funding. Academic authors were supported by the National Health and Medical Research Council, National Heart Foundation, and Western Sydney Local Health District.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Human Research Ethics Committee of Western Sydney Local Health District gave ethical approval for this work. (Project number 2020/ETH03085)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData produced in the present study can be made available upon reasonable request to the authors